Ipsen Limited is the UK subsidiary of Ipsen, a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2014 in more than 115 countries.
Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Ipsen's development strategy is supported by 3 franchises: endo-oncology, neurology, and uro-oncology. Ipsen's commitment to oncology is exemplified through its growing portfolio in prostate cancer, bladder cancer and neuroendocrine tumours.
The Group has more than 4,500 employees. – less